|Back to main|
New Stock Coverage: Noodles & Co Looks a Little Limp
Equities wore a crown of thorns as President Obama, who never
promised us a rose garden (even in
the Rose Garden
) and Congress continued to be at odds and Roseland, New
Jersey-based ADP announced decidedly iffy private payroll growth.
Both the Commander in Chief, always
inordinately fond of the first-person pronoun
, and Capitol Hill were politely reminded by the American people
that there is no "I" in
). (Just as well, on a day that stock nosedived an NYSE-worst
13.87%.) While Wall Street didn't do so well, with the
(INDEXDJX:.DJI) dropping for an eighth time in 10, there were
triple miracles on 34th Street. The
) Building owner bucked a bad tape to increase 0.77% after its IPO,
) jumped 1.22% - even if its
slave-driver bosses are total turkeys
Madison Square Garden
) - better than any rose garden - gained 0.17% after being
anointed the country's coolest arena
Today in economics, analysts expect to see a slippage in September's Institute for Supply Management services index at 10:00 a.m. Eastern. On the corporate earnings front, Comtech Telecommunications ( CMTL ), Constellation Brands (STZ), International Speedway (ISCA), and Xyratex (XRTX) are all due to release results.
Angie's List (ANGI): Shares, slumping before the bell after cutting certain membership prices by about 75%, are nonetheless initiated with a Buy at MKM Partners.
Arena Pharmaceuticals (ARNA): Cowen establishes a Market Perform rating and $4.50 price target on ARNA.
Coach (COH): COH is covered with a Buy opinion and $66 price objective at Cantor Fitzgerald, which is impressed with its sales momentum.
ExamWorks (EXAM): Needham assigns a Buy recommendation on EXAM, citing stable costs and increased market share. Its price objective is $31.
LivePerson (LPSN): Janney has a new Neutral on the business services name.
Mast Therapeutics (MSTX): Canaccord Genuity begins the biotech microcap, up impressively before the bell, with a Buy rating and $3 price target.
Murphy Oil (MUR): The energy outfit is a new Neutral at Credit Suisse, whose target price is $70.
Noodles & Co (NDLS): Shares are begun with an uninspiring Equal Weight rating at Barclays. Its objective is $39.
NPS Pharmaceuticals (NPSP): NPSP is a new Buy at Bank of America-Merrill Lynch.
Regions Financial (RF): Wunderlich resumes Buy-rated research and a $12 target on RF, highlighting the substantial discount its shares trade at relative to industry rivals.
TC Pipelines (TCP): RBC Capital launches Sector Perform rated coverage of the limited partnership. Its price objective is $51.
Tiffany & Co (TIF): Market share increases sees the upscale jeweler score a Buy initiation and $88 objective at Cantor.
Yara (OTCMKTS:YARIY): Barclays has a fresh Equal Weight on the fertilizer firm.
(See also: Stock Upgrades: Vivus Stock Is to Diet For and Stock Downgrades: Fair-Weather 'Friends' Flee Facebook .)